UPDATE: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of…
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total…